In honor of Ann Eisenberg, honoree for Hadassah Richmond’s Elinor Bloom Marshall Humanitarian Award, funds raised will go to Hadassah Hospital’s Neurology Department.
Hadassah Medical Organization (HMO) doctors and researchers in Israel are rapidly developing new treatments and cures in neurology for diseases like amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), age-related macular degeneration, Parkinson’s, Alzheimer’s and diabetes. With continued help from our generous donors, we hope to have new options for patients.
Among other things, researchers developed a new approach to Alzheimer’s disease, creating a cognitive health mobile app to achieve faster diagnosis and earlier intervention.
Impacts 10 Million People
While there are many unknowns about Parkinson’s – a disease that impacts 10 million people worldwide – Hadassah doctors in Israel are encouraged by their wealth of research.
“We are on the edge of a very exciting era, when we’ll have much better treatments” for Parkinson’s disease, said Dr. Dana Ekstein, chair of the Neurology Department at Hadassah Hospital. When asked if there will be a cure for Parkinson’s in the future, senior neurologist Dr. David Arkadir is optimistic. “I believe one day we’ll have one,” he said, adding, “Hopefully, one day we’ll also have a way to reverse it … it’s a very, very fast advancing field and Hadassah Hospital is at the forefront.”
Global Leaders in Medical Care
Supported by generous donors in the United States and around the world, HMO’s two Jerusalem hospitals are innovative and compassionate global leaders in medical care, treatments and research serving more than a million women, men and children a year, regardless of religion, race or nationality.
The Humanitarian Award will be presented at a (likely) virtual event on Sunday, Oct. 10.